Handelsbanken Fonder’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$28.5M Buy
364,319
+139,909
+62% +$10.9M 0.1% 188
2025
Q1
$16.3M Sell
224,410
-265,755
-54% -$19.3M 0.07% 261
2024
Q4
$36.3M Sell
490,165
-643,147
-57% -$47.6M 0.14% 140
2024
Q3
$74.8M Sell
1,133,312
-736,665
-39% -$48.6M 0.3% 70
2024
Q2
$173M Buy
1,869,977
+292,134
+19% +$27M 0.75% 19
2024
Q1
$151M Sell
1,577,843
-32,339
-2% -$3.09M 0.65% 21
2023
Q4
$123M Buy
1,610,182
+286,095
+22% +$21.8M 0.6% 29
2023
Q3
$91.7M Buy
1,324,087
+170,300
+15% +$11.8M 0.51% 36
2023
Q2
$109M Buy
1,153,787
+638,322
+124% +$60.2M 0.58% 30
2023
Q1
$42.6M Sell
515,465
-28,737
-5% -$2.38M 0.25% 95
2022
Q4
$40.6M Sell
544,202
-94,237
-15% -$7.03M 0.25% 92
2022
Q3
$52.8M Buy
638,439
+83,567
+15% +$6.91M 0.35% 57
2022
Q2
$52.8M Buy
554,872
+22,317
+4% +$2.12M 0.34% 63
2022
Q1
$62.7M Buy
532,555
+12,712
+2% +$1.5M 0.35% 59
2021
Q4
$67.3M Sell
519,843
-2,752
-0.5% -$357K 0.33% 64
2021
Q3
$59.2M Buy
522,595
+18,408
+4% +$2.08M 0.31% 66
2021
Q2
$52.2M Buy
504,187
+89,269
+22% +$9.25M 0.27% 83
2021
Q1
$34.7M Buy
414,918
+11,787
+3% +$986K 0.2% 112
2020
Q4
$36.8M Sell
403,131
-68,407
-15% -$6.24M 0.22% 104
2020
Q3
$37.6M Buy
471,538
+17,370
+4% +$1.39M 0.28% 82
2020
Q2
$31.4M Buy
+454,168
New +$31.4M 0.26% 87
2019
Q2
Sell
-204,000
Closed -$13M 191
2019
Q1
$13M Buy
204,000
+87,000
+74% +$5.55M 0.25% 101
2018
Q4
$5.97M Sell
117,000
-195,000
-63% -$9.96M 0.12% 139
2018
Q3
$18.1M Buy
312,000
+78,000
+33% +$4.53M 0.34% 90
2018
Q2
$11.4M Buy
+234,000
New +$11.4M 0.22% 119
2017
Q1
Sell
-85,500
Closed -$2.67M 172
2016
Q4
$2.67M Hold
85,500
0.08% 127
2016
Q3
$3.44M Buy
+85,500
New +$3.44M 0.1% 131
2016
Q2
Sell
-60,000
Closed -$1.76M 237
2016
Q1
$1.76M Sell
60,000
-67,695
-53% -$1.99M 0.08% 118
2015
Q4
$3.36M Buy
+127,695
New +$3.36M 0.07% 250